OncoSec Medical Inc (ONCSQ)

[hschlauch]

Those institutional numbers will probably change very soon - I think the multigene construct(s) may turn out to be a major technological disruption. This all assumes the genes transfer and the proteins become expressed well intratumorally.

I simply cannot imagine seeing major biotech companies producing recombinant proteins, including checkpoint inhibitors and other antibodies, just standing there watching a company with a cheaper, safer, and more effective IO platform just steamroll them. Oncosec may have the means to safely deliver a product that allows a patient's own body to produce a suite of therapeutic proteins that drive immunity in the presence of tumor specific antigens. Moreover, I think they have the potential to also encode checkpoint inhibitors on these multigene plasmids. And if that is indeed the case, this little company will be valued in the billions real quick.